INTERNATIONAL PATENT: UTC THERAPEUTICS (SHANGHAI) CO., LTD. FILES APPLICATION FOR "CD40-TARGETTING ANTIBODIES AND USES THEREOF"

GENEVA, May 11 -- UTC THERAPEUTICS (SHANGHAI) CO., LTD. (No. 4-5, Lane 100, Banxia RoadPudong New Area, Shanghai 201318) filed a patent application (PCT/CN2024/129735) for "CD40-TARGETTING ANTIBODIES AND USES THEREOF" on Nov 04, 2024. With publication no. WO/2025/093035, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHAO, Yangbing (Building 5, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), LIU, Xiaojun (Building 5, Lane 100, Banxia RoadPudong New Area, Shanghai 201318), ZHU, Gengzhen (Building 5, Lane 100, Banx...